{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:05:16Z","timestamp":1790255116124,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["WE 2589\/6-1"],"award-info":[{"award-number":["WE 2589\/6-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003107","name":"Bundesministerium f\u00fcr Gesundheit","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003107","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Oncology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.omton.2026.201285","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T23:48:26Z","timestamp":1782863306000},"page":"201285","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Depletion of IL-10 in CAR-NK cells augments reprogramming of the tumor microenvironment and ameliorates therapeutic efficacy"],"prefix":"10.1016","volume":"34","author":[{"given":"Anja","family":"L\u00f6we","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmin","family":"R\u00f6der","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline","family":"H\u00e4cker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Bhatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarete","family":"Mijatovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malena","family":"Schnieder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Kiefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"K\u00fchnel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten","family":"Tonn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Kaulich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Congcong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Weigert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9858-3643","authenticated-orcid":false,"given":"Winfried S.","family":"Wels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omton.2026.201285_bib1","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.cell.2020.03.001","article-title":"The emerging landscape of immune cell therapies","volume":"181","author":"Weber","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.omton.2026.201285_bib2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.imbio.2015.07.012","article-title":"Tricking the balance: NK cells in anti-cancer immunity","volume":"222","author":"Pahl","year":"2017","journal-title":"Immunobiology"},{"key":"10.1016\/j.omton.2026.201285_bib3","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41573-019-0052-1","article-title":"NK cells for cancer immunotherapy","volume":"19","author":"Shimasaki","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omton.2026.201285_bib4","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/s41573-022-00413-7","article-title":"Harnessing natural killer cells for cancer immunotherapy: dispatching the first responders","volume":"21","author":"Maskalenko","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omton.2026.201285_bib5","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1056\/NEJMoa1910607","article-title":"Use of CAR-transduced natural killer cells in CD19-positive lymphoid tumors","volume":"382","author":"Liu","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omton.2026.201285_bib6","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/s41591-023-02785-8","article-title":"Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19(+) B cell tumors: a phase 1\/2 trial","volume":"30","author":"Marin","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.omton.2026.201285_bib7","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0140-6736(24)02462-0","article-title":"Induced pluripotent stem-cell-derived CD19-directed chimeric antigen receptor natural killer cells in B-cell lymphoma: a phase 1, first-in-human trial","volume":"405","author":"Ghobadi","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.omton.2026.201285_bib8","first-page":"1083","article-title":"First-in-man clinical trial of CAR NK-92 cells: safety test of CD33-CAR NK-92 cells in patients with relapsed and refractory acute myeloid leukemia","volume":"8","author":"Tang","year":"2018","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.omton.2026.201285_bib9","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1093\/neuonc\/noad087","article-title":"Intracranial injection of natural killer cells engineered with a HER2-targeted chimeric antigen receptor in patients with recurrent glioblastoma","volume":"25","author":"Burger","year":"2023","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.omton.2026.201285_bib10","series-title":"Natural Killer Cells: At the Forefront of Modern Immunology","first-page":"1","article-title":"Engineered natural killer cell lines and their application for cancer immunotherapy","author":"K\u00fchnel","year":"2026"},{"key":"10.1016\/j.omton.2026.201285_bib11","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1016\/j.ymthe.2020.09.015","article-title":"CAR T cell therapy for solid tumors: Bright future or dark reality?","volume":"28","author":"Wagner","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omton.2026.201285_bib12","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/s41586-023-06945-1","article-title":"Natural killer cell therapies","volume":"626","author":"Vivier","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.omton.2026.201285_bib13","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1182\/blood-2005-03-1154","article-title":"Natural-killer cells and dendritic cells: \u201cl'union fait la force\u201d","volume":"106","author":"Walzer","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.omton.2026.201285_bib14","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3389\/fimmu.2014.00159","article-title":"Cross-talks between natural killer cells and distinct subsets of dendritic cells","volume":"5","author":"Ferlazzo","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omton.2026.201285_bib15","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv375","article-title":"ErbB2\/HER2-specific NK cells for targeted therapy of glioblastoma","volume":"108","author":"Zhang","year":"2016","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.omton.2026.201285_bib16","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3389\/fimmu.2017.00533","article-title":"Chimeric antigen receptor-engineered NK-92 cells: An off-the-shelf cellular therapeutic for targeted elimination of cancer cells and induction of protective antitumor immunity","volume":"8","author":"Zhang","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omton.2026.201285_bib17","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2022.2127508","article-title":"AAV-mediated gene transfer of a checkpoint inhibitor in combination with HER2-targeted CAR-NK cells as experimental therapy for glioblastoma","volume":"11","author":"Strecker","year":"2022","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.omton.2026.201285_bib18","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/s41416-025-02977-8","article-title":"CAR-NK cell therapy combined with checkpoint inhibition induces an NKT cell response in glioblastoma","volume":"132","author":"Strassheimer","year":"2025","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.omton.2026.201285_bib19","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/mt.2014.219","article-title":"Selective inhibition of tumor growth by clonal NK cells expressing an ErbB2\/HER2-specific chimeric antigen receptor","volume":"23","author":"Sch\u00f6nfeld","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omton.2026.201285_bib20","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1016\/j.ymthe.2025.04.033","article-title":"ErbB2\/HER2-targeted CAR-NK cells eliminate breast cancer cells in an organoid model that recapitulates tumor progression","volume":"33","author":"R\u00f6der","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omton.2026.201285_bib21","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00262-017-2055-2","article-title":"Clinical grade manufacturing of genetically modified, CAR-expressing NK-92 cells for the treatment of ErbB2-positive malignancies","volume":"67","author":"Nowakowska","year":"2018","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.omton.2026.201285_bib22","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1038\/s41598-017-02333-8","article-title":"NK cell-derived IL-10 is critical for DC-NK cell dialogue at the maternal-fetal interface","volume":"7","author":"Blois","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omton.2026.201285_bib23","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.chom.2009.11.003","article-title":"Systemic but not local infections elicit immunosuppressive IL-10 production by natural killer cells","volume":"6","author":"Perona-Wright","year":"2009","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.omton.2026.201285_bib24","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cellimm.2015.09.002","article-title":"Peripheral blood NK cells expressing HLA-G, IL-10 and TGF-\u03b2 in healthy donors and breast cancer patients","volume":"298","author":"Ostapchuk","year":"2015","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.omton.2026.201285_bib25","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/0092-8674(87)90086-9","article-title":"A C-terminal signal prevents secretion of luminal ER proteins","volume":"48","author":"Munro","year":"1987","journal-title":"Cell"},{"key":"10.1016\/j.omton.2026.201285_bib26","doi-asserted-by":"crossref","first-page":"23931","DOI":"10.1016\/S0021-9258(19)51027-4","article-title":"Intracellular expression of single chain antibodies reverts ErbB-2 transformation","volume":"269","author":"Beerli","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omton.2026.201285_bib27","article-title":"IL-10 enhances human natural killer cell effector functions via metabolic reprogramming regulated by mTORC1 signaling","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omton.2026.201285_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.947568","article-title":"The multifaceted role of STAT3 in NK-cell tumor surveillance","volume":"13","author":"Witalisz-Siepracka","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omton.2026.201285_bib29","doi-asserted-by":"crossref","first-page":"21053","DOI":"10.1016\/S0021-9258(19)36892-9","article-title":"Characterization of interleukin-10 receptors on human and mouse cells","volume":"268","author":"Tan","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omton.2026.201285_bib30","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0969-2126(01)00193-9","article-title":"Crystal structure of interleukin-10 reveals the functional dimer with an unexpected topological similarity to interferon gamma","volume":"3","author":"Zdanov","year":"1995","journal-title":"Structure"},{"key":"10.1016\/j.omton.2026.201285_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1063303","article-title":"Multiplexed engineering and precision gene editing in cellular immunotherapy","volume":"13","author":"Biederst\u00e4dt","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omton.2026.201285_bib32","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1016\/j.ymthe.2025.03.040","article-title":"Clinical development of allogeneic chimeric antigen receptor \u03b1\u03b2-T cells","volume":"33","author":"Georgiadis","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omton.2026.201285_bib33","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/s41571-025-01072-4","article-title":"Next-generation T cell immunotherapies engineered with CRISPR base and prime editing: challenges and opportunities","volume":"22","author":"Petri","year":"2025","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.omton.2026.201285_bib34","doi-asserted-by":"crossref","first-page":"8439","DOI":"10.1038\/s41467-024-52388-1","article-title":"CRISPR\/Cas9 editing of NKG2A improves the efficacy of primary CD33-directed chimeric antigen receptor natural killer cells","volume":"15","author":"Bexte","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omton.2026.201285_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2025.102636","article-title":"Off-target effects in CRISPR-Cas genome editing for human therapeutics: Progress and challenges","volume":"36","author":"Kalter","year":"2025","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omton.2026.201285_bib36","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1038\/s41587-022-01377-0","article-title":"Frequent aneuploidy in primary human T cells after CRISPR-Cas9 cleavage","volume":"40","author":"Nahmad","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omton.2026.201285_bib37","doi-asserted-by":"crossref","first-page":"4567","DOI":"10.1016\/j.cell.2023.08.041","article-title":"Mitigation of chromosome loss in clinical CRISPR-Cas9-engineered T cells","volume":"186","author":"Tsuchida","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.omton.2026.201285_bib38","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s40259-020-00419-w","article-title":"Applying antibodies inside cells: Principles and recent advances in neurobiology, virology and oncology","volume":"34","author":"Zhang","year":"2020","journal-title":"BioDrugs"},{"key":"10.1016\/j.omton.2026.201285_bib39","doi-asserted-by":"crossref","first-page":"7889","DOI":"10.1073\/pnas.90.16.7889","article-title":"Design, intracellular expression, and activity of a human anti-human immunodeficiency virus type 1 gp120 single-chain antibody","volume":"90","author":"Marasco","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omton.2026.201285_bib40","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0092-8674(92)90476-S","article-title":"Ligand-induced redistribution of a human KDEL receptor from the Golgi complex to the endoplasmic reticulum","volume":"68","author":"Lewis","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.omton.2026.201285_bib41","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/sj.gene.6364135","article-title":"IL-10 stimulatory effects on human NK cells explored by gene profile analysis","volume":"5","author":"Mocellin","year":"2004","journal-title":"Genes Immun."},{"key":"10.1016\/j.omton.2026.201285_bib42","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.4049\/jimmunol.162.7.3865","volume":"162","author":"Sato","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.omton.2026.201285_bib43","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s12026-011-8262-6","article-title":"Interleukin 10 in the tumor microenvironment: a target for anticancer immunotherapy","volume":"51","author":"Sato","year":"2011","journal-title":"Immunol. Res."},{"key":"10.1016\/j.omton.2026.201285_bib44","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.coi.2014.12.009","article-title":"Suppression of antigen presentation by IL-10","volume":"34","author":"Mittal","year":"2015","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.omton.2026.201285_bib45","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.3389\/fimmu.2019.02683","article-title":"CAR-engineered NK cells for the treatment of glioblastoma: Turning innate effectors into precision tools for cancer immunotherapy","volume":"10","author":"Burger","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omton.2026.201285_bib46","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1073\/pnas.89.7.2737","article-title":"Functional characterization of a hybrid human-mouse interferon gamma receptor: evidence for species-specific interaction of the extracellular receptor domain with a putative signal transducer","volume":"89","author":"Hemmi","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omton.2026.201285_bib47","doi-asserted-by":"crossref","first-page":"37426","DOI":"10.1074\/jbc.M102020200","article-title":"Identification of tumor necrosis factor (TNF) amino acids crucial for binding to the murine p75 TNF receptor and construction of receptor-selective mutants","volume":"276","author":"Ameloot","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omton.2026.201285_bib48","first-page":"652","article-title":"Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells","volume":"8","author":"Gong","year":"1994","journal-title":"Leukemia"},{"key":"10.1016\/j.omton.2026.201285_bib49","article-title":"Humanized anti-IL-10 antibodies for the treatment of systemic lupus erythematosus (SLE)","author":"Osterroth","year":"2012","journal-title":"United States patent application US2012\/0321617A1"},{"key":"10.1016\/j.omton.2026.201285_bib50","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1089\/10430340252898984","article-title":"High-level transduction and gene expression in hematopoietic repopulating cells using a human immunodeficiency virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter","volume":"13","author":"Demaison","year":"2002","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omton.2026.201285_bib51","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1007\/s00262-012-1212-x","article-title":"Expression of IL-15 in NK cells results in rapid enrichment and selective cytotoxicity of gene-modified effectors that carry a tumor-specific antigen receptor","volume":"61","author":"Sahm","year":"2012","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.omton.2026.201285_bib52","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-33592-8","article-title":"EzColocalization: An ImageJ plugin for visualizing and measuring colocalization in cells and organisms","volume":"8","author":"Stauffer","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omton.2026.201285_bib53","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.239","article-title":"Identification of tumor-associated macrophage subsets that are associated with breast cancer prognosis","volume":"10","author":"Strack","year":"2020","journal-title":"Clin. Transl. Med."}],"container-title":["Molecular Therapy Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S295032992600161X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S295032992600161X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:37:45Z","timestamp":1790253465000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S295032992600161X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S295032992600161X"],"URL":"https:\/\/doi.org\/10.1016\/j.omton.2026.201285","relation":{},"ISSN":["2950-3299"],"issn-type":[{"value":"2950-3299","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Depletion of IL-10 in CAR-NK cells augments reprogramming of the tumor microenvironment and ameliorates therapeutic efficacy","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omton.2026.201285","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"201285"}}